{
  "ticker": "EW",
  "year": 2022,
  "quarter": 3,
  "last_updated": "2025-04-15T12:45:33.214155",
  "count": 34,
  "transactions": [
    {
      "id": 11992,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12036,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 12032,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 11981,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27788,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 11985,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12020,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27834,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11993,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 27805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 11988,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 27800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 2297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12019,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27833,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 2279,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 2298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11998,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 12021,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 27835,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 2303,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 2317,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 12026,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 12042,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 27840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 27859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 2290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12012,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    }
  ]
}